AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIAID

NIH’s Dr. Dieffenbach Shares Final Update from AIDS 2016

Carl Anne Day 3 FB Live - resized

In his third and final update from the International AIDS Conference (AIDS 2016) in Durban, South Africa, NIH’s Dr. Carl Dieffenbach discussed highlights of ongoing HIV cure research presented at the conference. Dr. Dieffenbach, the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), spoke with his colleague…

HIV Vaccine Research: Update from NIH’s Dr. Dieffenbach from 2nd Day of AIDS 2016

Carl day 2 FB Live resized

As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via Facebook Live to get his thoughts on some of the day’s highlights. He is Director of the Division of AIDS at NIH’s National Institute of Allergy and…

Dr. Fauci and Dr. Wolitski Discuss Highlights of AIDS 2016

Fauci Facebook live interview - resized

During the second day of sessions at the International AIDS Conference (AIDS 2016) in Durban, South Africa, AIDS.gov did a Facebook Live session with Dr. Tony Fauci of NIH and Dr. Rich Wolitski of HHS at the U.S. government exhibit booth. Dr. Fauci is the Director of the National Institute of Allergy and Infectious Diseases…

HIV Therapy for Breastfeeding Mothers Can Virtually Eliminate Transmission to Babies

Logo for National Institute of Allergy and Infectious Disease

HIV Therapy for Breastfeeding Mothers Can Virtually Eliminate Transmission to Babies For HIV-infected mothers whose immune system is in good health, taking a three-drug antiretroviral regimen during breastfeeding essentially eliminates HIV transmission by breast milk to their infants, according to results from a large clinical trial conducted in sub-Saharan Africa and India. These findings from…

Vaginal Ring May Cut HIV Infection Risk if Used Consistently

Vaginal ring - cropped July 2016

NIH Clinical Trial Will Clarify Relationship between Ring Adherence, HIV Infection Risk A new exploratory analysis of data from the ASPIRE study has found that using a drug-infused vaginal ring most or all of the time reduced the risk of HIV infection in women by at least 56 percent. This finding is being reported today…

An AIDS-free world is possible, but do we have the will to achieve it?

About 100 demonstrators protested on the steps of New York's City Hall on Friday, Nov. 15, 1985 as a City Council committee considered legislation to bar pupils and teachers with the AIDS virus from public schools. (AP Photo/Rick Maiman)

Thirty-five years ago this week, our lives — and the lives of millions of people around the globe — changed forever with the publication of a report of five previously healthy gay men in Los Angeles diagnosed with Pneumocystis carinii pneumonia, a disease typically seen only in those with profoundly impaired immune function. As two…

NIH Statement on HIV Vaccine Awareness Day

HIV Vaccine Day 2016 - Fauci quote - cropped May2016

Advances in HIV/AIDS research have given us the opportunity to transform the lives of those living with HIV while providing highly effective methods of preventing the infection. This progress has strengthened optimism for achieving a durable end to the HIV/AIDS pandemic. With an estimated two million new HIV infections occurring worldwide annually, however, controlling and…

NIAID to Fund Further Study of Dapivirine Vaginal Ring for HIV Prevention Investment in HOPE Trial Augments Development of Next-Generation Prevention Tools

NIAID image - vaginal ring - ASPIRE study

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that it would move forward with an open-label extension study of an HIV prevention tool for women: a silicone ring that continuously releases the experimental antiretroviral drug dapivirine in the vagina. The new study builds on…